This activity focuses on the multidisciplinary care of liver and pancreatic cancer highlighting the role of radiation therapy.

Management of unknown primary head and neck squamous cell carcinomas has evolved as the incidence of p16 positive disease among head and neck cancer patients has increased.

Recent studies have led to radical change in concepts when considering Radiation Therapy for indolent lymphomas. This activity reviews clinical and practical updates in regards to dose considerations, patient selection and radiation techniques for this heterogenous group of patients.

A practicing radiation oncologist increasingly requires knowledge of the business and economic aspects of medical practice.

ASTRO CEO Vivek Kavadi, MD, MBA, FASTRO, conducts a strategic dialogue.
 

Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology.

This activity is designed for radiation oncologists, focusing on managing bone metastases. One of the three presentations exclusively explores stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. Supporting data guides discussions on SBRT's effectiveness and strategies.

This activity explores the use of repeat radiation for intra-cranial neoplasms. Radiation is the primary management modality for the treatment of a number of intracranial pathologies and the initial treatment is well studied and relatively standardized across the specialty.

This activity involves three discussants using case-based presentations to review challenging areas of breast cancer management. The first discussant examines the options for treating patients with recurrent breast cancer.

The introduction of novel therapies for gynecologic malignancies such as immunotherapy, SBRT and complex brachytherapy can lead to increased frequency of severe toxicities for which treatment options may be limited.